New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with transcatheter aortic valve replacement ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.

Engineered for strength and durability, the standard AWWA C508 Swing Check Valve offering features an ASTM A536 ductile iron ...

Is this new sleeping setup from Sea to Summit the one outdoor sleep system to rule them all? We doss down in the wild to find out.